National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$44.00
add to cart

Rights & Permissions

topleft topright

Rare Diseases and Orphan Products: Accelerating Research and Development (2011)
Board on Health Sciences Policy (HSP)

Citation Manager

. "Appendix E: Rare Diseases Clinical Research Network." Rare Diseases and Orphan Products: Accelerating Research and Development. Washington, DC: The National Academies Press, 2011.

Please select a format:

BibTeX EndNote RefMan


Page
368
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Rare Diseases and Orphan Products: Accelerating Research and Development

North American Mitochondrial Diseases Consortium

AID: aminoglycoside-induced deafness

Alpers syndrome

CoQ deficiency

CPEO: chronic progressive external ophthalmoplegia

DAD: diabetes and deafness

Encephalopathy

Encephalomyopathy

FBSN: familial bilateral striatal necrosis

Hepatocerebral disease

KSS: Kearns-Sayre syndrome

Leigh syndrome

Leukoencephalopathy

LHON: Leber’s hereditary optic neuropathy

MELAS: mitochondrial encephalopathy lactic acidosis with stroke-like episodes

MERRF: Myoclonus epilepsy ragged-red fibers

MILS: maternally inherited Leigh syndrome

MNGIE: Mitochondrial neurogastrointestinal encephalomyopathy

Mitochondrial DNA depletion syndrome

Multiple deletions of mitochondrial DNA

NARP: Neuropathy, ataxia and retinitis pigmentosa syndrome

Pearson syndrome

SANDO: Sensory ataxia neuropathy dysarthria ophthalmoplegia

Complex I deficiency

Complex II (SDH) deficiency

Complex III deficiency

Complex IV deficiency

Complex V deficiency

Multiple respiratory chain enzyme deficiencies


Porphyria Consortium

Acute intermittent porphyria

Hereditary coproporphyria

Variegate porphyria

Aminolevulinate dehydratase deficiency porphyria

Porphyria cutanea tarda

Hepatoerythropoietic porphyria

Congenital porphyria

Erythropoietic protoporphyria and X-linked protoporphyria


Primary Immune Deficiency Treatment Consortium

Severe combined immunodeficiency (SCID)

Page
368